Astrocyte Reactivity Mediated by LCN2 Promotes Synaptic Loss in Alzheimer's Dis…

Mechanistic description

Lipocalin-2 (LCN2), secreted by reactive astrocytes, binds to astrocytic LCN2R and triggers iron-dependent ferroptosis of neighboring synapses. LCN2 elevation correlates with cognitive decline independent of amyloid burden, offering an amyloid-independent mechanism. However, the hypothesis suffers from multiple fundamental weaknesses: (1) LCN2R remains poorly characterized with questionable specificity; (2) no GWAS support for LCN2 or related iron metabolism genes in AD risk; (3) ferroptosis evidence comes from in vitro models with non-physiological iron concentrations; (4) LCN2 elevation may be an adaptive acute-phase response rather than a toxin; (5) iron chelation trials in AD showed limited efficacy, undermining the ferroptosis mechanism. The hypothesis received the lowest confidence from both the Skeptic (0.48) and is the least supported by human genetics.

Mechanism / pathway

LCN2
→
neurodegeneration

Evidence for (3)

LCN2 upregulated in reactive astrocytes; PMID 29999565

PMID:29999565
LCN2 mediates iron-dependent cell death in some contexts; PMID related
Ferroptosis mechanisms characterized in neurodegeneration; PMID 31873289

PMID:31873289

Evidence against (5)

No LCN2 or iron metabolism gene variants associated with AD risk in large GWAS
LCN2R identity unresolved—proposed receptors have questionable specificity
Iron chelation trials (deferoxamine, deferasirox) showed limited cognitive benefit
LCN2 is acute-phase reactant—elevation may be protective adaptive response
Astrocyte heterogeneity means not all astrocytes express LCN2—relevant subpopulation undefined

Evidence matrix

3 supporting 5 contradicting

38% supporting

Supporting

LCN2 upregulated in reactive astrocytes; PMID 29999565 PMID:29999565
LCN2 mediates iron-dependent cell death in some contexts; PMID related
Ferroptosis mechanisms characterized in neurodegeneration; PMID 31873289 PMID:31873289

Contradicting

No LCN2 or iron metabolism gene variants associated with AD risk in large GWAS
LCN2R identity unresolved—proposed receptors have questionable specificity
Iron chelation trials (deferoxamine, deferasirox) showed limited cognitive benefit
LCN2 is acute-phase reactant—elevation may be protective adaptive response
Astrocyte heterogeneity means not all astrocytes express LCN2—relevant subpopulation undefined

Cite this hypothesis

Citation

etl-backfill (2026). Astrocyte Reactivity Mediated by LCN2 Promotes Synaptic Loss in Alzheimer's Dis…. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/h-942b276bdd

BibTeX

@misc{scidex_hypothesis_h942b276,
  title        = {Astrocyte Reactivity Mediated by LCN2 Promotes Synaptic Loss in Alzheimer's Dis…},
  author       = {etl-backfill},
  year         = {2026},
  howpublished = {SciDEX hypothesis},
  url          = {https://prism.scidex.ai/hypotheses/h-942b276bdd},
  note         = {SciDEX artifact hypothesis:h-942b276bdd}
}